Latest Breaking News On - Impact pharmaceutical services - Page 1 : comparemela.com

/PRNewswire/ Riverside Partners, a Boston based private equity firm, announced today that its portfolio company, Syner-G BioPharma Group ("Syner-G" or the.

United statesRon krausRandy merrillDavid belluckPrabu nambiarParexel internationalImpact pharmaceutical servicesBiopharma groupRiverside partnersSynerg biopharma groupChief executive officerChief operating officerGlobal headParexel consultingCraig sternGeneral partner